Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.

Kuchling J, Backner Y, Oertel FC, Raz N, Bellmann-Strobl J, Ruprecht K, Paul F, Levin N, Brandt AU, Scheel M.

Neuroimage Clin. 2018 May 8;19:538-550. doi: 10.1016/j.nicl.2018.05.004. eCollection 2018.

2.

Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study.

Oertel FC, Havla J, Roca-Fernández A, Lizak N, Zimmermann H, Motamedi S, Borisow N, White OB, Bellmann-Strobl J, Albrecht P, Ruprecht K, Jarius S, Palace J, Leite MI, Kuempfel T, Paul F, Brandt AU.

J Neurol Neurosurg Psychiatry. 2018 Jun 19. pii: jnnp-2018-318382. doi: 10.1136/jnnp-2018-318382. [Epub ahead of print]

PMID:
29921610
3.

MRI-Based Methods for Spinal Cord Atrophy Evaluation: A Comparison of Cervical Cord Cross-Sectional Area, Cervical Cord Volume, and Full Spinal Cord Volume in Patients with Aquaporin-4 Antibody Seropositive Neuromyelitis Optica Spectrum Disorders.

Chien C, Brandt AU, Schmidt F, Bellmann-Strobl J, Ruprecht K, Paul F, Scheel M.

AJNR Am J Neuroradiol. 2018 Jul;39(7):1362-1368. doi: 10.3174/ajnr.A5665. Epub 2018 May 10.

PMID:
29748202
4.

Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated Syndrome.

Zimmermann HG, Knier B, Oberwahrenbrock T, Behrens J, Pfuhl C, Aly L, Kaminski M, Hoshi MM, Specovius S, Giess RM, Scheel M, Mühlau M, Bellmann-Strobl J, Ruprecht K, Hemmer B, Korn T, Paul F, Brandt AU.

JAMA Neurol. 2018 Apr 23. doi: 10.1001/jamaneurol.2018.1011. [Epub ahead of print]

PMID:
29710121
5.

Frequent retinal ganglion cell damage after acute optic neuritis.

Brandt AU, Specovius S, Oberwahrenbrock T, Zimmermann HG, Paul F, Costello F.

Mult Scler Relat Disord. 2018 May;22:141-147. doi: 10.1016/j.msard.2018.04.006. Epub 2018 Apr 9.

PMID:
29704802
6.

Multicenter reliability of semiautomatic retinal layer segmentation using OCT.

Oberwahrenbrock T, Traber GL, Lukas S, Gabilondo I, Nolan R, Songster C, Balk L, Petzold A, Paul F, Villoslada P, Brandt AU, Green AJ, Schippling S.

Neurol Neuroimmunol Neuroinflamm. 2018 Mar 13;5(3):e449. doi: 10.1212/NXI.0000000000000449. eCollection 2018 May.

7.

Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.

Oertel FC, Zimmermann H, Paul F, Brandt AU.

EPMA J. 2017 Dec 22;9(1):21-33. doi: 10.1007/s13167-017-0123-5. eCollection 2018 Mar. Review.

8.

Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.

Backner Y, Kuchling J, Massarwa S, Oberwahrenbrock T, Finke C, Bellmann-Strobl J, Ruprecht K, Brandt AU, Zimmermann H, Raz N, Paul F, Levin N.

JAMA Neurol. 2018 Mar 1;75(3):287-295. doi: 10.1001/jamaneurol.2017.3880.

PMID:
29297053
9.

Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization.

Finke C, Zimmermann H, Pache F, Oertel FC, Chavarro VS, Kramarenko Y, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

JAMA Neurol. 2018 Mar 1;75(3):296-303. doi: 10.1001/jamaneurol.2017.3890.

PMID:
29297041
10.

Safety and preliminary efficacy of deep transcranial magnetic stimulation in MS-related fatigue.

Gaede G, Tiede M, Lorenz I, Brandt AU, Pfueller C, Dörr J, Bellmann-Strobl J, Piper SK, Roth Y, Zangen A, Schippling S, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 13;5(1):e423. doi: 10.1212/NXI.0000000000000423. eCollection 2018 Jan.

11.

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing.

Grobelny A, Behrens JR, Mertens S, Otte K, Mansow-Model S, Krüger T, Gusho E, Bellmann-Strobl J, Paul F, Brandt AU, Schmitz-Hübsch T.

PLoS One. 2017 Dec 15;12(12):e0189281. doi: 10.1371/journal.pone.0189281. eCollection 2017.

12.

Self-perception and determinants of color vision in Parkinson's disease.

Brandt AU, Zimmermann HG, Oberwahrenbrock T, Isensee J, Müller T, Paul F.

J Neural Transm (Vienna). 2018 Feb;125(2):145-152. doi: 10.1007/s00702-017-1812-x. Epub 2017 Nov 15.

PMID:
29143216
13.

[Optical coherence tomography in neuromyelitis optica spectrum disorders].

Oertel FC, Zimmermann H, Brandt AU, Paul F.

Nervenarzt. 2017 Dec;88(12):1411-1420. doi: 10.1007/s00115-017-0444-6. Review. German.

PMID:
29119196
14.

Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community.

Eaneff S, Wang V, Hanger M, Levy M, Mealy MA, Brandt AU, Eek D, Ratchford JN, Nyberg F, Goodall J, Wicks P.

Mult Scler Relat Disord. 2017 Oct;17:116-122. doi: 10.1016/j.msard.2017.07.014. Epub 2017 Jul 11.

15.

Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Kuchling J, Brandt AU, Paul F, Scheel M.

EPMA J. 2017 Jul 25;8(3):279-294. doi: 10.1007/s13167-017-0102-x. eCollection 2017 Sep. Review.

16.

CuBe: parametric modeling of 3D foveal shape using cubic Bézier.

Yadav SK, Motamedi S, Oberwahrenbrock T, Oertel FC, Polthier K, Paul F, Kadas EM, Brandt AU.

Biomed Opt Express. 2017 Aug 22;8(9):4181-4199. doi: 10.1364/BOE.8.004181. eCollection 2017 Sep 1.

17.

Synergistic Strategy for Multicolor Two-photon Microscopy: Application to the Analysis of Germinal Center Reactions In Vivo.

Rakhymzhan A, Leben R, Zimmermann H, Günther R, Mex P, Reismann D, Ulbricht C, Acs A, Brandt AU, Lindquist RL, Winkler TH, Hauser AE, Niesner RA.

Sci Rep. 2017 Aug 2;7(1):7101. doi: 10.1038/s41598-017-07165-0.

18.

Brain activity, regional gray matter loss, and decision-making in multiple sclerosis.

Weygandt M, Wakonig K, Behrens J, Meyer-Arndt L, Söder E, Brandt AU, Bellmann-Strobl J, Ruprecht K, Gold SM, Haynes JD, Paul F.

Mult Scler. 2018 Aug;24(9):1163-1173. doi: 10.1177/1352458517717089. Epub 2017 Jun 28.

PMID:
28657480
19.

Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.

Albrecht P, Blasberg C, Ringelstein M, Müller AK, Finis D, Guthoff R, Kadas EM, Lagreze W, Aktas O, Hartung HP, Paul F, Brandt AU, Methner A.

J Neurol. 2017 Jul;264(7):1370-1380. doi: 10.1007/s00415-017-8532-x. Epub 2017 Jun 5.

PMID:
28584914
20.

Contribution of blood vessels to retinal nerve fiber layer thickness in NMOSD.

Oertel FC, Zimmermann H, Mikolajczak J, Weinhold M, Kadas EM, Oberwahrenbrock T, Pache F, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 18;4(3):e338. doi: 10.1212/NXI.0000000000000338. eCollection 2017 May. No abstract available.

21.

Single-subject independent component analysis-based intensity normalization in non-quantitative multi-modal structural MRI.

Papazoglou S, Würfel J, Paul F, Brandt AU, Scheel M.

Hum Brain Mapp. 2017 Apr 22. doi: 10.1002/hbm.23615. [Epub ahead of print]

PMID:
28432780
22.

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.

Gieß RM, Pfuhl C, Behrens JR, Rasche L, Freitag E, Khalighy N, Otto C, Wuerfel J, Brandt AU, Hofmann J, Eberspächer B, Bellmann-Strobl J, Paul F, Ruprecht K.

PLoS One. 2017 Apr 7;12(4):e0175279. doi: 10.1371/journal.pone.0175279. eCollection 2017.

23.

Monitoring the Course of MS With Optical Coherence Tomography.

Brandt AU, Martinez-Lapiscina EH, Nolan R, Saidha S.

Curr Treat Options Neurol. 2017 Apr;19(4):15. doi: 10.1007/s11940-017-0452-7. Review.

PMID:
28374232
24.

Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.

Oertel FC, Kuchling J, Zimmermann H, Chien C, Schmidt F, Knier B, Bellmann-Strobl J, Korn T, Scheel M, Klistorner A, Ruprecht K, Paul F, Brandt AU.

Neurol Neuroimmunol Neuroinflamm. 2017 Feb 22;4(3):e334. doi: 10.1212/NXI.0000000000000334. eCollection 2017 May.

25.

Histopathologic Assessment of Neurotoxicity after Repeated Administration of Gadodiamide in Healthy Rats.

Schlemm L, Radbruch H, Brandt AU, Scheel M, Paul F.

Radiology. 2017 Mar;282(3):925-926. doi: 10.1148/radiol.2017162394. No abstract available.

PMID:
28218886
26.

Severe structural and functional visual system damage leads to profound loss of vision-related quality of life in patients with neuromyelitis optica spectrum disorders.

Schmidt F, Zimmermann H, Mikolajczak J, Oertel FC, Pache F, Weinhold M, Schinzel J, Bellmann-Strobl J, Ruprecht K, Paul F, Brandt AU.

Mult Scler Relat Disord. 2017 Jan;11:45-50. doi: 10.1016/j.msard.2016.11.008. Epub 2016 Nov 20.

PMID:
28104256
27.

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life.

Krüger T, Behrens JR, Grobelny A, Otte K, Mansow-Model S, Kayser B, Bellmann-Strobl J, Brandt AU, Paul F, Schmitz-Hübsch T.

BMC Neurol. 2017 Jan 13;17(1):10. doi: 10.1186/s12883-016-0783-0.

28.

Longitudinal Intravital Imaging of the Retina Reveals Long-term Dynamics of Immune Infiltration and Its Effects on the Glial Network in Experimental Autoimmune Uveoretinitis, without Evident Signs of Neuronal Dysfunction in the Ganglion Cell Layer.

Bremer D, Pache F, Günther R, Hornow J, Andresen V, Leben R, Mothes R, Zimmermann H, Brandt AU, Paul F, Hauser AE, Radbruch H, Niesner R.

Front Immunol. 2016 Dec 23;7:642. doi: 10.3389/fimmu.2016.00642. eCollection 2016.

29.

Accuracy and Reliability of the Kinect Version 2 for Clinical Measurement of Motor Function.

Otte K, Kayser B, Mansow-Model S, Verrel J, Paul F, Brandt AU, Schmitz-Hübsch T.

PLoS One. 2016 Nov 18;11(11):e0166532. doi: 10.1371/journal.pone.0166532. eCollection 2016.

30.

Stress-induced brain activity, brain atrophy, and clinical disability in multiple sclerosis.

Weygandt M, Meyer-Arndt L, Behrens JR, Wakonig K, Bellmann-Strobl J, Ritter K, Scheel M, Brandt AU, Labadie C, Hetzer S, Gold SM, Paul F, Haynes JD.

Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):13444-13449. Epub 2016 Nov 7.

31.

Whole-body positional manipulators for ocular imaging of anaesthetised mice and rats: a do-it-yourself guide.

Dietrich M, Cruz-Herranz A, Yiu H, Aktas O, Brandt AU, Hartung HP, Green A, Albrecht P.

BMJ Open Ophthalmol. 2016 Nov 6;1(1):e000008. doi: 10.1136/bmjophth-2016-000008. eCollection 2017.

32.

Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.

Mikolajczak J, Zimmermann H, Kheirkhah A, Kadas EM, Oberwahrenbrock T, Muller R, Ren A, Kuchling J, Dietze H, Prüss H, Paul F, Hamrah P, Brandt AU.

Mult Scler. 2017 Dec;23(14):1847-1853. doi: 10.1177/1352458516677590. Epub 2016 Nov 3.

PMID:
27811337
33.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.

Jarius S, Kleiter I, Ruprecht K, Asgari N, Pitarokoili K, Borisow N, Hümmert MW, Trebst C, Pache F, Winkelmann A, Beume LA, Ringelstein M, Stich O, Aktas O, Korporal-Kuhnke M, Schwarz A, Lukas C, Haas J, Fechner K, Buttmann M, Bellmann-Strobl J, Zimmermann H, Brandt AU, Franciotta D, Schanda K, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):281.

34.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.

Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, Oertel FC, Bellmann-Strobl J, Jarius S, Wildemann B, Reindl M, Waldman A, Soelberg K, Asgari N, Ringelstein M, Aktas O, Gross N, Buttmann M, Ach T, Ruprecht K, Paul F, Brandt AU; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Nov 1;13(1):282.

35.

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Chavarro VS, Mealy MA, Simpson A, Lacheta A, Pache F, Ruprecht K, Gold SM, Paul F, Brandt AU, Levy M.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 24;3(6):e286. eCollection 2016 Dec.

36.

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.

Cameron JR, Albrecht P, Cruz-Herranz A, Petzold A, Lagreze WA, Brandt AU.

Neurology. 2016 Nov 1;87(18):1960. No abstract available.

PMID:
27799477
37.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 27;13(1):280.

38.

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Trebst C, Ringelstein M, Aktas O, Winkelmann A, Buttmann M, Schwarz A, Zimmermann H, Brandt AU, Franciotta D, Capobianco M, Kuchling J, Haas J, Korporal-Kuhnke M, Lillevang ST, Fechner K, Schanda K, Paul F, Wildemann B, Reindl M; in cooperation with the Neuromyelitis Optica Study Group (NEMOS).

J Neuroinflammation. 2016 Sep 26;13(1):279.

39.

Afferent Visual Pathway Affection in Patients with PMP22 Deletion-Related Hereditary Neuropathy with Liability to Pressure Palsies.

Brandt AU, Meinert-Bohn E, Rinnenthal JL, Zimmermann H, Mikolajczak J, Oberwahrenbrock T, Papazoglou S, Pfüller CF, Schinzel J, Tackenberg B, Paul F, Hahn K, Bellmann-Strobl J.

PLoS One. 2016 Oct 17;11(10):e0164617. doi: 10.1371/journal.pone.0164617. eCollection 2016.

40.

Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.

Schlemm L, Chien C, Bellmann-Strobl J, Dörr J, Wuerfel J, Brandt AU, Paul F, Scheel M.

Mult Scler. 2017 Jun;23(7):963-972. doi: 10.1177/1352458516670738. Epub 2016 Sep 27.

PMID:
27679460
41.

Accuracy and repeatability of two methods of gait analysis - GaitRite™ und Mobility Lab™ - in subjects with cerebellar ataxia.

Schmitz-Hübsch T, Brandt AU, Pfueller C, Zange L, Seidel A, Kühn AA, Paul F, Minnerop M, Doss S.

Gait Posture. 2016 Jul;48:194-201. doi: 10.1016/j.gaitpost.2016.05.014. Epub 2016 May 25.

PMID:
27289221
42.

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.

Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P; IMSVISUAL consortium.

Neurology. 2016 Jun 14;86(24):2303-9. doi: 10.1212/WNL.0000000000002774. Epub 2016 May 25.

43.

Normal volumes and microstructural integrity of deep gray matter structures in AQP4+ NMOSD.

Finke C, Heine J, Pache F, Lacheta A, Borisow N, Kuchling J, Bellmann-Strobl J, Ruprecht K, Brandt AU, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e229. doi: 10.1212/NXI.0000000000000229. eCollection 2016 Jun.

44.

Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Pache F, Zimmermann H, Finke C, Lacheta A, Papazoglou S, Kuchling J, Wuerfel J, Hamm B, Ruprecht K, Paul F, Brandt AU, Scheel M.

Eur Radiol. 2016 Dec;26(12):4413-4422. Epub 2016 Mar 24.

PMID:
27012555
45.

Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.

Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P; IMSVISUAL consortium.

Lancet Neurol. 2016 May;15(6):574-84. doi: 10.1016/S1474-4422(16)00068-5. Epub 2016 Mar 18.

PMID:
27011339
46.

Visual dysfunction, but not retinal thinning, following anti-NMDA receptor encephalitis.

Brandt AU, Oberwahrenbrock T, Mikolajczak J, Zimmermann H, Prüss H, Paul F, Finke C.

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 2;3(2):e198. doi: 10.1212/NXI.0000000000000198. eCollection 2016 Apr.

47.

Validity of visual perceptive computing for static posturography in patients with multiple sclerosis.

Behrens JR, Mertens S, Krüger T, Grobelny A, Otte K, Mansow-Model S, Gusho E, Paul F, Brandt AU, Schmitz-Hübsch T.

Mult Scler. 2016 Oct;22(12):1596-1606. Epub 2016 Jan 26.

PMID:
26814201
48.

Characterizing the phenotype of multiple sclerosis-associated depression in comparison with idiopathic major depression.

Hasselmann H, Bellmann-Strobl J, Ricken R, Oberwahrenbrock T, Rose M, Otte C, Adli M, Paul F, Brandt AU, Finke C, Gold SM.

Mult Scler. 2016 Oct;22(11):1476-1484. Epub 2016 Jan 8.

PMID:
26746809
49.

Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.

Hoffmann S, Siedler J, Brandt AU, Piper SK, Kohler S, Sass C, Paul F, Reilmann R, Meisel A.

BMC Neurol. 2015 Dec 23;15:265. doi: 10.1186/s12883-015-0517-8.

50.

No Evidence for Retinal Damage Evolving from Reduced Retinal Blood Flow in Carotid Artery Disease.

Heßler H, Zimmermann H, Oberwahrenbrock T, Kadas EM, Mikolajczak J, Brandt AU, Kauert A, Paul F, Schreiber SJ.

Biomed Res Int. 2015;2015:604028. doi: 10.1155/2015/604028. Epub 2015 Oct 19.

Supplemental Content

Loading ...
Support Center